When was Protocol First founded?

Protocol First was founded in 2015 and raised its 1st funding round 5 years after it was founded.

Where is Protocol First located?

Protocol First is headquartered in Alamo, United States.

How many employees does Protocol First have?

As of Jul 01, 2024, the latest employee count at Protocol First is 10.

Is Protocol First a funded company?

Protocol First is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on May 19, 2020.

When was the latest funding round of Protocol First?

Protocol First's latest funding was a $***** Seed round on May 19, 2020, with participation from 1 investor. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $703M in funding in 2026 to date.

Where does Protocol First rank among its competitors?

Protocol First ranks 27th amongst 61 active competitors, of which 10 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Vida Lung, which secured $10.8M in Sep, 2023.

Who are the top competitors of Protocol First?

Protocol First's top competitors include Suvoda, Vida Lung and HumanFirst. Among them, Vida Lung secured the most recent funding round in September, 2023.

Protocol First - 2026 Company Profile, Team, Funding & Competitors

Protocol First is a seed company based in Alamo (United States), founded in 2015 by Hugh Levaux. It operates as a Transforming cancer care through technology, data, and research solutions. Protocol First has raised an undisclosed amount in funding from Leukemia & Lymphoma Society. The company has 61 active competitors, including 10 funded and 5 that have exited. Its top competitors include companies like Suvoda, Vida Lung and HumanFirst.

Company Details

Transforming cancer care through technology, data, and research solutions. The company is dedicated to improving and extending lives by learning from the experience of every person with cancer. They provide technology and services to support patient care and accelerate research. Their vision is to bridge the gap between care and research, offering solutions that span clinical research, real-world evidence, and point-of-care applications. The company's product portfolio includes tools for patient identification, data transfer, clinical trial management, and diversity planning. They empower sponsors, contract research organizations, and clinical trial sites with technology-enabled services and operations. The company focuses on driving operational efficiencies, accelerating research timelines, and improving patient outcomes through innovative technology and data-driven insights. They offer software and technology solutions for healthcare, clinical trials, and oncology research.

Key Metrics

Founded Year

2015

Location

Alamo, United States

Stage

Seed

Latest Funding Round

Seed, May 19, 2020, $*****

Investors

Leukemia & Lymphoma Society

Ranked

27^th among 61 active competitors

Employee Count

10 as on Jul 01, 2024

Similar Companies

Suvoda & 93 more

View Protocol First's full profile

Protocol First has raised funding over 1 round. Its latest funding round was a Seed round on May 19, 2020 for $*****. 1 investor participated in its latest round. Protocol First has 1 institutional investor.

Here is the list of recent funding rounds of Protocol First:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 19, 2020	8035233	Seed	8412270	3266717	6338968	9782111

Access funding benchmarks and valuations. Sign up today!

View details of Protocol First's funding rounds and investors

The founders of Protocol First is Hugh Levaux.

Here are the details of Protocol First's key team members:

Hugh Levaux: Founder & CEO of Protocol First.
Contact Info: 1 email address

View details of Protocol First's Founder profiles and Board Members

Protocol First's employee count trend

Protocol First has 10 employees as of Jul 24. Here is Protocol First's employee count trend over the years:

Uncover Protocol First's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Protocol First include Suvoda, Vida Lung and HumanFirst. Here is the list of Top 10 competitors of Protocol First, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Suvoda 2012, Conshohocken (United States), Acquired	Provider of clinical trial management solution	$40M	LLR Partners	57/100
2nd	Vida Lung 2004, Coralville (United States), Series C	Provider of clinical trial software and analysis services for lung diseases	$35.9M	Next Level Ventures, OSF HealthCare & 15 others	55/100
3rd	HumanFirst 2017, San Francisco (United States), Acquired	Remote monitoring platform for healthcare professionals	$15M	Maverick Ventures, Lux Capital & 19 others	51/100
4th	RealTime eClinical Solutions 2011, San Antonio (United States), Late Stage	Provider of technology that enables clinical research sites to streamline trial execution and improve compliance	-	LLR Partners	47/100
5th	Curavit 2019, Boston (United States), Series A	Contract research organization that offers a complete suite of CRO services for decentralized clinical trials	$16.4M	Osage Venture Partners, Royal Street Ventures ... & 1 others	45/100
6th	MedAvante-ProPhase 2002, Hamilton (United States), Acquired	Provider of eSource data capture solutions for clinical trials	$2.29M	Spring Mountain Capital, Gal Ventures	44/100
7th	CRScube 2010, Seoul (South Korea), Unfunded	Provider of clinical research solutions	-	-	43/100
8th	Data Matrix 2009, Petersburg (United States), Series A	Comprehensive online platform for lottery enthusiasts with diverse betting options	$2.61M	IIDF, Primer Capital	37/100
9th	Brite Health 2015, California (United States), Funding Raised	Provides a monitoring solution for clinical trial engagement	-	Stanford Angels & Entrepreneurs, Plug and Play Tech Center ... & 2 others	36/100
10th	Signet Accel 2014, Columbus (United States), Series A	Uncensored adult entertainment: live sex cams, chatrooms, and performers	$8M	Edison Partners	35/100
27th	Protocol First 2015, Alamo (United States), Seed	Transforming cancer care through technology, data, and research solutions	-	Leukemia & Lymphoma Society	25/100